human
sever
acut
respiratori
syndrom
hsar
first
major
new
infecti
diseas
centuryi
unusu
high
mortal
infect
rate
acut
respiratori
ill
caus
infect
human
sar
corona
viru
hsarscov
probabl
origin
wild
reservoir
novel
corona
viru
relat
previous
document
corona
virus
larg
confin
domest
anim
speci
cross
speci
barrier
new
variant
form
spread
new
extrem
virul
sar
viru
infect
human
led
first
global
pandem
centuri
peopl
becam
infect
die
intens
research
led
complet
genom
sequenc
sarscov
within
six
month
report
prevent
strategi
sar
infect
attent
drawn
develop
effect
vaccin
viru
also
necessari
therapeut
option
avail
alreadi
infect
current
treatment
avail
rapidli
spread
infect
normal
patient
contract
syndrom
administ
common
antivir
drug
minim
result
kept
isol
quarantin
research
past
three
year
indic
among
mani
target
fusogen
envelop
glycoprotein
sarscov
also
call
spike
protein
major
target
therapi
spike
protein
mediat
viral
fusion
deliveri
viral
genom
host
cell
consequ
proteintarget
approach
appli
initi
stage
infect
like
reduc
infect
within
beyond
respiratori
organ
recent
report
protein
proteolyt
process
membranebound
furin
member
mammalian
subtilas
proprotein
convertas
pc
cleavag
occur
rntr
flev
site
lead
format
two
matur
fragment
ntermin
ctermin
figur
fragment
human
sever
acut
respiratori
syndrom
coronaviru
hsarscov
caus
agent
sar
infect
surfac
glycoprotein
spike
protein
consid
one
prime
target
sar
therapeut
intervent
proteolyt
matur
host
proteas
crucial
hostviru
fusion
use
intramolecularli
quench
fluorogen
iqf
peptid
base
hsarscov
spike
protein
gluglnaspargasnthrarggluvalphealagln
tyxnh
vitro
studi
show
besid
furin
pc
like
might
also
involv
cleavag
event
kinet
measur
recombin
pc
observ
peptid
cleav
effici
furin
poorli
cleavag
could
block
pcinhibitor
dosedepend
manner
circular
dichroism
spectra
indic
peptid
possess
high
degre
sheet
structur
follow
cleavag
furin
sheet
content
increas
possibl
expens
turn
random
structur
h
nmr
spectra
cosi
roesi
experi
physiolog
buffer
ph
condit
indic
peptid
possess
structur
turn
ctermin
segment
close
cleavag
site
data
suggest
cleavabl
peptid
bond
locat
within
expos
domain
support
nearbi
turn
structur
sever
strong
weak
nmr
roesi
correl
detect
structur
spike
iqf
peptid
contain
crucial
cleavag
site
r
fle
propos
distinct
biolog
function
follow
cleavag
globular
part
protein
mediat
bind
host
cellsurfac
receptor
angiotensin
convert
enzym
segment
residu
protein
identifi
receptorbind
domain
conserv
domain
form
membraneanchor
stalk
region
mediat
virushost
cell
fusion
exvivo
studi
vero
cell
also
reveal
two
membranebound
pc
name
cleav
protein
compar
studi
efficaci
made
either
membranebound
solubl
cterminaltrunc
form
regard
work
need
pc
implic
proteolyt
matur
larg
number
viral
glycoprotein
contain
pcrecognit
motif
cleavag
site
work
conduct
vitro
compar
studi
cleavag
hsar
protein
solubl
form
furin
use
intramolecularli
quench
model
fluorogen
iqf
peptid
deriv
protein
cleavag
site
also
investig
abil
pc
inhibitor
block
cleavag
moreov
examin
solutionphas
structur
peptid
use
circular
dichroism
cd
h
nmr
spectroscopi
studi
found
c
h
u
n
g
r
e
n
n
u
n
g
import
structur
conform
featur
protein
near
crucial
activ
site
cd
spectroscopi
use
determin
secondari
structur
sever
sarscovderiv
peptid
variou
condit
nmr
data
use
determin
solutionphas
structur
condit
mimic
physiolog
environ
number
iqf
peptid
base
potenti
pc
cleavag
site
hsarscov
spike
protein
prepar
use
solidphas
fmoc
chemistri
see
experiment
section
locat
peptid
variou
import
domain
spike
protein
includ
heptad
repeat
transmembran
domain
shown
figur
use
iqf
model
peptid
chemic
synthesi
iqf
peptid
carri
solidphas
fmoc
chemistri
base
variou
step
repetit
fmoc
deprotect
amid
coupl
use
hatu
diea
figur
c
peptid
electron
transfer
take
place
donor
abz
function
acceptor
nitrotyrosin
moieti
lead
quench
fluoresc
properti
figur
b
select
peptid
guid
primarili
presenc
pc
sequenc
recognit
motif
size
cleav
band
obtain
coinfect
experi
fulllength
hsarscov
spike
protein
individu
fulllength
pc
among
iqf
peptid
test
found
cleav
significantli
furin
vide
infra
therefor
peptid
subject
investig
evalu
conform
secondari
structur
vitro
digest
peptid
furin
initi
compar
studi
digest
peptid
solubl
form
convertas
furin
achiev
rphplc
analysi
crude
digest
thu
evid
furin
similar
level
enzym
activ
compar
determin
activesit
titrat
inhibitor
decrvkrcmk
assay
cleav
peptid
effici
correct
physiolog
site
r
fle
confirm
mass
spectra
data
hplc
peak
figur
thu
upon
cleavag
gluglnaspargasnthrarggluvalphealagln
tyxnh
retent
time
r
min
w
da
gener
two
addit
peak
r
min
ntermin
fragment
nt
abzgluglnaspargasnthrargoh
w
da
ctermin
fragment
ct
gluvalphealaglntyxnh
w
da
respect
peak
area
correspond
nt
ct
fragment
significantli
higher
furin
digest
compar
digest
fact
intens
fragment
peak
weak
hplc
chromatogram
digest
base
peak
height
area
estim
peptid
cleav
furin
cleav
ident
condit
figur
tabl
amount
cleavag
though
small
still
consid
signific
compar
observ
similar
system
measur
kinet
paramet
v
max
k
k
cat
michaelismenten
plot
determin
v
max
k
digest
peptid
solubl
recombin
furin
shown
figur
measur
kinet
paramet
present
tabl
amount
activ
enzym
e
pc
sampl
determin
activesit
titrat
use
coval
inhibitor
decrvkrcmk
assum
pc
enzym
inactiv
stoichiometr
ratio
case
trypsin
tlck
tosyl
lysin
chloromethyl
keton
data
show
among
three
solubl
pc
examin
furin
potent
enzym
cleav
r
fle
site
vitro
measur
k
cat
k
ratio
furin
digest
mm
h
better
correspond
valu
digest
respect
note
lowest
k
valu
obtain
furin
suggest
stronger
interact
substrat
moreov
highest
k
cat
valu
obtain
lowest
indic
rapid
slow
turnov
two
enzym
respect
mg
digest
furin
u
ml
h
presenc
increas
amount
pc
inhibitor
cleavag
gradual
diminish
confirm
gradual
decreas
peak
intens
ctcleav
fragment
r
min
rphplc
chromatogram
amount
pc
inhibitor
gradual
increas
mm
figur
suggest
block
pcmediat
cleavag
peptid
observ
differ
retent
time
peptid
peak
hplc
shown
figur
due
differ
hplc
column
type
gradient
method
use
note
mm
almost
suffici
block
furinmedi
u
ml
cleavag
peptid
mg
complet
h
period
ident
undigest
cleav
ctfragment
peptid
fulli
confirm
mass
spectrometri
hplc
purif
cd
spectroscopi
perform
peptid
aqueou
medium
variou
concentr
analyz
depend
secondari
structur
concentr
shown
figur
overal
spectral
profil
chang
significantli
concentr
suggest
secondari
structur
peptid
remain
larg
unchang
expect
peak
intens
chang
concentr
upon
softwar
analysi
cd
spectra
found
helic
structur
present
peptid
concentr
use
possess
predominantli
b
sheet
structur
content
mg
ml
increas
margin
concentr
c
h
u
n
g
r
e
n
n
u
n
g
decreas
mg
ml
occur
mostli
expens
random
structur
decreas
concentr
decreas
mg
ml
subsequ
digest
experi
concentr
peptid
fix
mg
ml
cd
spectra
concentr
strong
enough
good
structur
evalu
upon
digest
mg
ml
min
increas
amount
furin
sheet
content
increas
slightli
mainli
expens
turn
structur
remain
less
constant
tabl
also
display
overlay
cd
spectra
figur
b
even
incub
perform
longer
period
time
h
much
chang
notic
cd
spectra
thu
signific
chang
occur
immedi
follow
initi
contact
furin
addit
furin
seem
alter
cd
spectra
signific
extent
cd
spectra
shown
figur
b
net
spectra
obtain
follow
subtract
appropri
control
spectra
data
indic
even
long
period
digest
h
mixtur
undigest
cleav
fragment
still
exhibit
predominantli
sheet
structur
presenc
high
sheet
content
peptid
found
cd
studi
full
agreement
nmr
result
vide
infra
possibl
differ
peptid
concentr
differ
condit
use
two
studi
see
experiment
section
proton
amino
acid
assign
base
analysi
cosi
hsqc
tocsi
roesi
spectra
aromat
proton
assign
base
primarili
cosi
correl
although
sometim
partial
overlap
among
individu
peptid
proton
proton
buffer
amino
acid
proton
could
assign
tocsi
pattern
posit
variou
b
g
aromat
backbon
nh
amid
proton
shown
figur
support
inform
amid
aproton
ntermin
glutam
acid
assign
ppm
base
roesi
correl
abz
aromat
orthoproton
glutam
acid
amid
nh
proton
figur
support
inform
due
similar
tocsi
pattern
figur
support
inform
spin
system
origin
amid
proton
ppm
two
amino
acid
assign
glutam
acid
respect
analog
twospin
system
origin
amid
proton
ppm
assign
glutamin
two
glutamin
two
arginin
distinguish
base
roesi
correl
amid
aproton
neighbor
amino
acid
figur
support
inform
addit
assign
aminoacid
proton
roesi
correl
neighbor
distant
wwwchembiochemorg
amino
acid
also
list
figur
indic
arrow
interact
proton
although
signific
overlap
contour
base
assign
roesi
correl
indic
presenc
bend
peptid
figur
addit
small
roesi
correl
figur
support
inform
nh
ctermin
glutam
acid
one
bproton
phenylalanin
provid
evid
bend
peptid
base
rphplc
analysi
crude
digest
measur
kinet
paramet
observ
peptid
cleav
effici
solubl
furin
form
correct
physiolog
r
fle
site
solubl
also
cleav
peptid
poor
effici
reflect
low
k
cat
k
valu
compar
furin
interestingli
k
cat
k
valu
high
cleavag
compar
furin
cleavag
overal
catalyt
effici
furin
base
k
cat
k
ratio
nearli
better
vitro
result
indic
furin
major
host
candid
enzym
involv
cleavag
order
studi
kinet
specif
abovedescrib
digest
experi
perform
examin
effect
pc
inhibitor
peptid
cleavag
data
show
cleavag
could
block
vitro
dosedepend
manner
known
potent
furin
pc
inhibitor
bioengin
variant
cleavag
sequenc
aipm
mutat
ripr
mimic
pcfurin
recognit
motif
sever
studi
demonstr
abil
block
proteolyt
event
mediat
pc
includ
furin
vitro
vivo
model
proteolyt
event
play
crucial
role
tumorigenesi
cancer
metastasi
obes
bacteri
viral
infect
therefor
pc
inhibitor
like
find
import
biochem
therapeut
applic
metabol
condit
howev
studi
fulllength
spike
protein
need
examin
potenti
applic
studi
sar
infect
previou
studi
demonstr
pc
inhibitor
decrvkrcmk
abl
diminish
sar
viral
infect
vero
cell
line
regard
great
interest
studi
compar
abil
variou
pc
inhibitor
includ
small
peptid
nonpeptid
molecul
suppress
sar
protein
process
consequ
cd
data
suggest
peptid
contain
crucial
sarscov
spike
protein
cleavag
site
rntr
flev
possess
larg
bsheet
structur
turn
random
structur
even
though
vitro
assess
base
model
peptid
studi
valuabl
futur
investig
crystal
structur
fulllength
protein
order
establish
relev
observ
physiolog
event
theoret
analysi
secondari
structur
sever
segment
hsar
spike
protein
perform
use
softwar
peptid
companion
well
webbas
program
http
wwwexpasych
segment
select
region
protein
contain
sequenc
compris
peptid
base
choufasman
conform
paramet
polypeptid
predict
turn
conform
within
drnt
segment
high
conform
potenti
magnitud
prefer
type
structur
directli
next
turn
either
side
although
sheet
helic
region
upand
downstream
note
structur
predict
around
cleavag
region
consist
measur
cd
h
nmr
data
studi
show
rel
content
b
sheet
structur
use
monitor
cleavag
min
incub
enzym
b
sheet
content
peptid
increas
slightli
howev
extend
period
time
percentag
b
sheet
structur
decreas
suggest
furin
bind
prior
cleavag
promot
structur
b
sheet
content
contrast
furin
cleav
peptid
overal
less
b
sheet
structur
even
though
chang
small
still
signific
nmr
data
suggest
peptid
mostli
linear
possibl
b
turn
n
terminu
structur
like
stabil
particip
hydrogen
bond
sever
residu
n
terminu
includ
amino
acid
residu
around
cleavag
site
indic
sequenc
gluglnaspargasnthrarg
flglu
underlin
residu
indic
exact
region
turn
thu
crucial
arg
residu
situat
turn
structur
critic
arg
residu
present
immedi
follow
turn
structur
mani
short
longdist
proa
c
h
u
n
g
r
e
n
n
u
n
g
tonproton
interact
shown
nmr
spectroscopi
figur
support
inform
support
structur
like
closerang
interact
help
stabil
propos
structur
around
cleavag
site
protein
import
point
similar
sar
glycoprotein
process
hiv
type
avian
ebola
chickungunya
virus
viral
glycoprotein
might
also
possess
similar
structur
featur
cleavag
site
studi
progress
laboratori
investig
hypothesi
present
vitro
studi
model
fluorogen
spike
peptid
confirm
crucial
role
host
proprotein
convertas
furin
cleavag
hsarscov
protein
lead
format
two
function
activ
distinct
fragment
studi
also
reveal
almost
effect
furin
cleav
peptid
like
involv
proteolyt
event
also
demonstr
cleavag
could
block
dosedepend
manner
nmr
studi
near
physiolog
ph
condit
show
possibl
presenc
b
turn
close
proxim
cleavag
site
type
secondari
structur
could
repres
uniqu
common
featur
viral
glycoprotein
process
host
pc
best
knowledg
one
first
attempt
demonstr
presenc
specif
secondari
structur
near
cleavag
site
nmr
cd
studi
studi
viral
glycoprotein
requir
confirm
gener
applic
hypothesi
concept
sar
intervent
might
feasibl
pc
furin
inhibitor
challeng
sever
observ
furin
cleavag
glycoprotein
relat
ebola
viru
import
vitro
infect
function
rais
question
therapeut
potenti
furin
inhibitor
sar
infect
coupl
step
extend
cycl
min
use
complet
synthesi
peptid
cleav
fulli
deprotect
resin
describ
previous
crude
peptid
purifi
rphplc
rainin
dynamax
instrument
equip
pump
use
column
jupit
phenomenex
first
semiprepar
column
size
cm
follow
analyt
column
size
cm
buffer
system
compris
aqueou
tfa
vv
solut
organ
phase
ch
cn
also
contain
tfa
vv
peptid
elut
min
linear
gradient
aqueou
tfach
cn
flow
rate
adjust
ml
min
analyt
run
ml
min
semiprepar
run
follow
min
isocrat
tfach
cn
peak
detect
uv
absorb
optic
densiti
measur
nm
collect
lyophil
analyz
malditof
mass
spectrometri
amino
acid
analysi
ntermin
microsequenc
carri
determin
peptid
ident
amino
acid
analysi
amino
acid
analysi
perform
hydrolysi
purifi
peptid
nmol
hcl
n
ml
seal
tube
vacuum
h
follow
ion
chromatographi
dionex
oakvil
canada
describ
refer
detect
two
unnatur
amino
acid
abz
tyx
authent
sampl
use
standard
confirm
exact
elut
time
chromatogram
ntermin
microsequenc
ntermin
microsequenc
purifi
peptid
conduct
use
edman
degrad
procis
instrument
appli
biosystem
foster
citi
ca
usa
typic
pmol
peptid
use
analysi
inform
full
aminoacid
sequenc
obtain
two
unnatur
amino
acid
abz
tyx
authent
sampl
use
standard
along
mixtur
natur
amino
acid
mass
spectra
measur
malditof
ms
perform
voyag
de
pro
pe
biosystem
inc
framingham
usa
instrument
use
ml
sampl
satur
chca
dhb
energyabsorb
matrix
sourc
enzym
activesit
titrat
solubl
truncat
form
recombin
human
furin
hfurin
kda
enzym
activ
u
per
ml
purchas
new
england
biolab
ipswich
usa
one
unit
activ
defin
amount
furin
releas
pmol
free
amc
fluorogen
peptid
bocrvrrmca
total
reaction
volum
ml
one
minut
pmol
amc
per
min
hepe
mm
ph
cacl
mm
mm
studi
conduct
fivefold
dilut
stock
furin
enzym
activ
u
ml
two
solubl
truncat
form
recombin
use
studi
obtain
crude
concentr
cultur
media
follow
partial
purif
describ
previous
solubl
lack
transmembran
domain
solubl
amino
acid
long
solubl
amino
acid
long
enzym
appropri
dilut
use
produc
nearli
ident
level
enzym
activ
u
ml
exact
amount
activ
enzym
prepar
determin
activesit
titrat
freshli
prepar
solut
decrvkrcmk
abovement
buffer
circular
dichrom
spectra
cd
spectra
record
ambient
temperatur
water
ph
use
spectropolarimet
easton
md
usa
mm
thick
rectangular
quartz
cell
total
volum
ml
peptid
concentr
studi
except
dosedepend
experi
maintain
mg
ml
spectra
measur
nm
record
nm
interv
spectrum
record
least
three
consecut
time
averag
cd
spectrum
blank
buffer
subtract
final
spectrum
analyz
use
cd
estima
softwar
softsec
program
softwood
co
brookfield
ct
usa
determin
content
variou
secondari
structur
name
helix
b
pleatedsheet
b
turn
random
cd
spectra
first
measur
peptid
alon
variou
concentr
examin
concentr
effect
secondari
structur
later
cd
spectra
also
measur
peptid
fix
concentr
mg
ml
incub
increas
level
solubl
recombin
furin
ml
u
activ
min
h
digest
iqf
peptid
vitro
digest
peptid
mg
carri
h
buffer
ml
consist
tri
mm
me
mm
nmorpholino
ethanesulfon
acid
cacl
mm
ph
solubl
recombin
furin
ml
u
ml
activ
reaction
stop
addit
glacial
acet
acid
ml
digest
analyz
individu
rphplc
analyt
column
condit
describ
except
rate
flow
maintain
ml
min
percentag
digest
determin
base
peak
area
height
use
either
formula
estim
intens
ctcleav
fragment
use
higher
optic
densiti
effect
inhibitor
furin
cleavag
mg
digest
h
furin
ml
u
ml
activ
absenc
presenc
increas
amount
mg
without
preincub
result
crude
digest
analyz
use
rphplc
malditof
ms
collect
peak
determin
kinet
paramet
v
max
k
k
cat
measur
v
max
k
k
cat
solubl
enzym
ml
furin
almost
ident
level
activ
incub
h
variou
concentr
peptid
mm
abovement
buffer
ml
microtit
plate
rate
hydrolysi
measur
chang
fluoresc
intens
valu
transform
mmol
h
peptid
cleav
use
standard
curv
quench
correct
data
collect
duplic
valu
mean
three
independ
experi
v
max
k
k
cat
calcul
describ
identifi
site
cleavag
digest
analyz
rphplc
use
analyt
column
follow
malditof
mass
spectrometri
isol
peak
consist
earlier
studi
note
signific
intermolecular
quench
releas
fluoresc
materi
undigest
substrat
especi
higher
substrat
concentr
correct
use
standard
quench
curv
c
h
u
n
g
r
e
n
n
u
n
g
describ
refer
nmr
spectroscopi
h
nmr
spectra
acquir
bruker
avanc
mhz
spectromet
bruker
biospin
boston
usa
use
invers
detect
peptid
mm
dissolv
buffer
consist
tri
mm
me
mm
cacl
mm
ph
spectra
acquir
use
solvent
suppress
techniqu
follow
bruker
puls
program
cosi
cosydfesgpphm
hsqc
hsqcedetgp
tocsi
mlevesgpph
roesi
roesygesgpph
tocsi
roesi
spectra
acquir
use
spin
lock
mix
time
ms
ms
respect
assign
proton
made
evalu
comparison
nmr
spectra
